Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

disodium ascorbyl campestanyl phosphate

Known as: disodium ascorbyl phytostanol phosphate 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
BackgroundMany drugs are substrates for P-glycoprotein (P-gp) and interactions involving P-gp may be relevant to clinical… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2012
2012
An in vitro lipolysis model was utilized to study the effect of stigmastanol (lipophilic phytosterol) and disodium ascorbyl… Expand
  • figure 3
  • figure 2
  • figure 4
  • table 1
Review
2008
Review
2008
Low-density lipoprotein-cholesterol (LDL-C) lowering is the mainstay of the current treatment guidelines in the management of… Expand
2008
2008
  • K. Bergmann
  • European Journal of Clinical Pharmacology
  • 2008
  • Corpus ID: 30317950
The Adult Treatment Panel III (ATP III) Guidelines [1] have revised the treatment goals for the reduction of lowdensity… Expand
2006
2006
OBJECTIVE The aim of this study was to investigate the effects of different phytosterols and their analogs on colonic mucosal… Expand
  • table 1
  • figure 1
  • figure 2
2005
2005
The aim of this study was to assess the efficacy of a novel water-soluble phytostanol anolog, disodium ascorbyl phytostanyl… Expand
  • table 1